CanTreatCOVID research study aims to identify effective, affordable and evidence-based medications for COVID that would reduce emergency department visits and hospital stays and help people feel better faster. The long-term goal of CanTreatCOVID is to find medications that prevent post-COVID condition, also known as long COVID. Listed below are different ways to share and get involved in the study.

Study materials

Use the following materials to share the CanTreatCOVID study with friends, family, community, and networks. If you have questions about the materials or study, email info@CanTreatCOVID.org.

Posters

Click the links below to download the CanTreatCOVID recruitment posters for display in your clinic or organization. If you want printed copies delivered to your site, email info@CanTreatCOVID.org.

• Recruitment poster 1
• Recruitment poster 2

Share the study with your colleagues and networks:

• One-page summary of CanTreatCOVID (PDF)
• One-page summary of CanTreatCOVID (Word document)

Social media

Share CanTreatCOVID on social media:

• Twitter
• Facebook
• LinkedIn

For Primary Care Providers

Primary care providers can refer any patient with a positive COVID test if

• aged 18-49 years with one or more chronic condition(s) OR
• aged 50+ years

Share the study with your colleagues and networks:

• One-page summary of CanTreatCOVID (PDF)
• One-page summary of CanTreatCOVID (Word document)
• CanTreatCOVID recruitment poster 1 (PDF)
• CanTreatCOVID recruitment poster 2 (PDF)

Why partner with us?

• We will help you save time. You can refer patients to our study, and we will screen if they are eligible to receive COVID medications, including Paxlovid. This research is a randomized controlled trial; if eligible, your patient will be randomized to either active treatment or usual care.
• This study is the fastest way to answer whether these medications are effective, particularly in a highly vaccinated population.
  
• This is by primary care providers, for primary care providers! CanTreatCOVID is helping us launch the new Canadian Primary Care Trials Network, finally creating evidence in the real world of primary care.

For Pharmacists

Why partner with us?

• We will help you save time. You can refer adults who tested positive for COVID to our study, and we will screen if they are eligible to receive COVID medications, including Paxlovid. This research is a randomized controlled trial; if eligible, your patient will be randomized to either active treatment or usual care.
• You will be part of Canada’s largest COVID research project.

How to get involved?

• You can refer participants to the study:
  • Adults aged 50+ years OR 18-49 years with 1+ chronic medical condition or who are immunosuppressed
  • With positive SARS-CoV-2 test (PCR or RAT) within 5 days of symptom onset
• We will provide study posters and other materials for display in your pharmacy
• Research Assistants will visit your pharmacy to hand out study flyers

To partner with us or for any questions, email our study pharmacists, Norman Umali or Cresti Hanna, at info@cantreatcovid.org or call 1-888-888-3308.

Flyers for pharmacists